Accretion Pharmaceuticals (NSE:ACCPL) Cash per Share: ₹3.62 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
22 GF Score
Price ₹202.00
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals Cash per Share?

Accretion Pharmaceuticals NSE:ACCPL -0.97% 22 Cash per Share is ₹3.62 as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 22/100. The stock has 6 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Accretion Pharmaceuticals's Cash per Share for the quarter that ended in Mar. 2026 was ₹3.62.

Accretion Pharmaceuticals  (NSE:ACCPL) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Accretion Pharmaceuticals Cash per Share Related Terms

Accretion Pharmaceuticals Cash per Share Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Cash per Share Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Cash per Share
0.34 0.03 0.08 0.05 3.62

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash per Share Get a 7-Day Free Trial 0.08 0.00 0.05 0.14 3.62
NSE:ACCPL
22GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Accretion Pharmaceuticals's Cash per Share for the fiscal year that ended in Mar. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=40.206/11.1
=3.62

Accretion Pharmaceuticals's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=40.206/11.1
=3.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of ₹3.62 mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a Cash per Share of ₹3.62 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Accretion Pharmaceuticals and its competitors.
Is Accretion Pharmaceuticals' Cash per Share too high?
Accretion Pharmaceuticals' current Cash per Share is ₹3.62. Overall, Accretion Pharmaceuticals has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Cash per Share compare to LLY and JNJ?
Accretion Pharmaceuticals' Cash per Share of ₹3.62 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Drug Manufacturers company?
A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current Cash per Share is ₹3.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Cash per Share of ₹3.62. The current Cash per Share is ₹3.62. Accretion Pharmaceuticals' overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Cash per Share is ₹3.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
22GF Score

Get the complete analysis for NSE:ACCPL

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹202.00
Price